Merck (MRK) Dividends payables (2009 - 2026)

Merck (MRK) has 18 years of Dividends payables data on file, last reported at $2.1 billion in Q1 2026.

• Dividends payables for Q1 2026 came in at $2.1 billion, up 3.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 3.18% YoY), and the FY2025 annual result was $2.1 billion, up 2.69% from the prior year.
• Dividends payables held at $2.1 billion in Q1 2026 per MRK's latest filing, from $2.1 billion in the prior quarter.
• Over five years, Dividends payables peaked at $2.1 billion in Q1 2026 and troughed at $1.8 billion in Q2 2022.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 frame the typical range for Dividends payables.
• The sharpest annual moves came in 2023 and 2025: Dividends payables advanced 7.68% in 2023, then increased 2.69% in 2025.
• A 5-year view of Dividends payables shows it stood at $1.9 billion in 2022, then increased by 5.36% to $2.0 billion in 2023, then grew by 4.99% to $2.1 billion in 2024, then grew by 2.69% to $2.1 billion in 2025, then rose by 0.14% to $2.1 billion in 2026.
• Business Quant data shows MRK's Dividends payables at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.0 billion in Q3 2025.